<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Syndromol</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Syndromol</journal-id>
<journal-id journal-id-type="publisher-id">MSY</journal-id>
<journal-title-group>
<journal-title>Molecular Syndromology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1661-8769</issn>
<issn pub-type="epub">1661-8777</issn>
<publisher>
<publisher-name>S. Karger AG</publisher-name>
<publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH-4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.com</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">32021607</article-id>
<article-id pub-id-type="pmc">6995944</article-id>
<article-id pub-id-type="doi">10.1159/000505279</article-id>
<article-id pub-id-type="publisher-id">msy-0010-0327</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Novel Insights from Clinical Practice</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Interstitial 4q Deletion Syndrome Including <italic>NR3C2</italic> Causing Pseudohypoaldosteronism</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Barone Pritchard</surname>
<given-names>Amanda</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ritter</surname>
<given-names>Alyssa</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kearney</surname>
<given-names>Hutton M.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Izumi</surname>
<given-names>Kosuke</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
</contrib-group>
<aff id="aff1"><sup>a</sup>Division of Human Genetics, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA</aff>
<aff id="aff2"><sup>b</sup>Division of Pediatric Genetics, Metabolism, and Genomic Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA</aff>
<aff id="aff3"><sup>c</sup>Division of Laboratory Genetics and Genomics, Mayo Clinic, Rochester, MN, USA</aff>
<author-notes>
<corresp id="cor1">*Amanda Barone Pritchard, MD, Division of Pediatric Genetics, Metabolism, and Genomic Medicine, Department of Pediatrics, C.S. Mott Children's Hospital, Michigan Medicine, D5240 Medical Professional Building, 1500 E Medical Center Drive, Ann Arbor, MI 48109 (USA), E-Mail <email>abarone@med.umich.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>1</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>7</month>
<year>2020</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>10</volume>
<issue>6</issue>
<fpage>327</fpage>
<lpage>331</lpage>
<history>
<date date-type="accepted">
<day>20</day>
<month>11</month>
<year>2019</year>
</date>
<date date-type="subscription-year">
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 by S. Karger AG, Basel</copyright-statement>
<copyright-year>2019</copyright-year>
</permissions>
<abstract>
<p>Interstitial and terminal deletions of chromosome 4q have been described for many years and have variable phenotypes depending on the size of the deletion present. Clinical features can include developmental delay, growth difficulty, digital differences, dysmorphic features, and cardiac anomalies. Here, we present an infant with pseudohypoaldosteronism found to have a deletion of 4q31.21q31.23, including <italic>NR3C2.</italic> Heterozygous mutations in <italic>NR3C2</italic> have been reported to cause autosomal dominant pseudohypoaldosteronism type 1 (PHA1A). This represents a rare case of PHA1A due to a contiguous interstitial deletion and highlights the importance of evaluating patients with overlapping deletions for PHA1A.</p>
</abstract>
<kwd-group>
<title>Keywords</title>
<kwd>Chromosomal microarray</kwd>
<kwd>Deletion syndrome</kwd>
<kwd>
<italic>NR3C2</italic>
</kwd>
<kwd>Pseudohypoaldosteronism</kwd>
<kwd>4q- syndrome</kwd>
</kwd-group>
<counts>
<fig-count count="1"></fig-count>
<ref-count count="17"></ref-count>
<page-count count="5"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>